Skip to main content
  •   Home
  •   Download
  •   Manual
  •   Contact

Natural Product (NP) Details

General Information of the NP (ID: NP3615)
Name
Piceatannol
Synonyms
piceatannol; 10083-24-6; 3-Hydroxyresveratol; piceatanol; astringinin; 3,5,3',4'-Tetrahydroxystilbene; (E)-4-(3,5-dihydroxystyryl)benzene-1,2-diol; 3,3',4'5-Tetrahydroxystilbene; 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol; 3,3',4,5'-Tetrahydroxystilbene; UNII-6KS3LS0D4F; NSC 365798; NSC-365798; NSC 622471; 6KS3LS0D4F; CHEMBL69863; 3,3',4,5'-Stilbenetetrol; 4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]benzene-1,2-diol; 4339-71-3; CHEBI:28814; C14H12O4; NSC365798; NSC622471; 1,2-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-
    Click to Show/Hide
Species Origin Rhodomyrtus tomentosa ...     Click to Show/Hide
Rhodomyrtus tomentosa
Kingdom: Viridiplantae
Phylum: Streptophyta
Class: Magnoliopsida
Order: Myrtales
Family: Myrtaceae
Genus: Rhodomyrtus
Species: Rhodomyrtus tomentosa
Disease Cytomegalovirus infection [ICD-11: 1A24] Investigative [1]
Structure
Click to Download Mol
2D MOL

3D MOL

    Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product
Formula
C14H12O4
PubChem CID
667639
Canonical SMILES
C1=CC(=C(C=C1C=CC2=CC(=CC(=C2)O)O)O)O
InChI
1S/C14H12O4/c15-11-5-10(6-12(16)8-11)2-1-9-3-4-13(17)14(18)7-9/h1-8,15-18H/b2-1+
InChIKey
CDRPUGZCRXZLFL-OWOJBTEDSA-N
CAS Number
CAS 10083-24-6
ChEBI ID
CHEBI:28814
Herb ID
HBIN039816
ETMC ID
1583
TTD Drug ID
D0O0VZ
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. A List of Drug(s) Whose Efficacy can be Enhanced by This NP
          Gemcitabine      Solid tumour/cancer     Click to Show/Hide the Molecular Data of This Drug
                 Augmenting Drug Sensitivity     Click to Show/Hide
                    Representative Experiment Reporting the Effect of This Combination [2]
                    Detail(s)  Combination Info  click to show the detail info of this combination
                    Molecule(s)
                    Regulation
Up-regulation Expression BAK  Molecule Info 
Pathway MAP
                    In-vitro Model A-549 CVCL_0023 Lung adenocarcinoma Homo sapiens
                    Experimental
                    Result(s)
Piceatannol can enhance the cytotoxic effects of gemcitabine by enhancing expression of the proapoptotic protein Bak.
Target and Pathway
Target(s) Interferon regulatory factor 3 (IRF3)  Molecule Info  [3]
KEGG Pathway Toll-like receptor signaling pathway Click to Show/Hide
2 RIG-I-like receptor signaling pathway
3 Cytosolic DNA-sensing pathway
4 Pertussis
5 Hepatitis C
6 Hepatitis B
7 Measles
8 Influenza A
9 Herpes simplex infection
10 Epstein-Barr virus infection
11 Viral carcinogenesis
Panther Pathway Toll receptor signaling pathway Click to Show/Hide
Reactome ISG15 antiviral mechanism Click to Show/Hide
2 LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
3 Interferon gamma signaling
4 Interferon alpha/beta signaling
5 TRAF3-dependent IRF activation pathway
6 TRAF6 mediated IRF7 activation
7 Negative regulators of RIG-I/MDA5 signaling
8 Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon
9 Factors involved in megakaryocyte development and platelet production
WikiPathways Toll-like receptor signaling pathway Click to Show/Hide
2 Cytosolic sensors of pathogen-associated DNA
3 MyD88-independent cascade
4 ISG15 antiviral mechanism
5 Apoptosis
6 RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways
7 Factors involved in megakaryocyte development and platelet production
8 Regulation of toll-like receptor signaling pathway
References
Reference 1 Inhibitory effects of piceatannol on human cytomegalovirus (hCMV) in vitro. J Microbiol. 2020 Aug;58(8):716-723.
Reference 2 Piceatannol Enhances the Antitumor Efficacy of Gemcitabine in Human A549 Non-Small Cell Lung Cancer Cells. Oncol Res. 2014;22(4):213-217.
Reference 3 Inhibition of lipopolysaccharide-induced interferon regulatory factor 3 activation and protection from septic shock by hydroxystilbenes. Shock. 2004 May;21(5):470-5.
 Download Picture         KEGG Link      
Cite NPCDR
Visitor Map
Correspondence

X. N. Sun, Y. T. Zhang, Y. Zhou, X. C. Lian, L. L. Yan, T. Pan, T. Jin, H. Xie, Z. M. Liang, W. Q. Qiu, J. X. Wang, Z. R. Li, F. Zhu*, X. B. Sui*. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Research. 50(D1): 1324-1333 (2020). PMID: 34664659

Prof. Feng ZHU  (zhufeng@zju.edu.cn)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China


Prof. Xinbing SUI  (hzzju@hznu.edu.cn)

School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China